What does CUSIP 405024100 represent in this 13F holders report?

CUSIP 405024100 is the security identifier for HAE - HAEMONETICS CORP - Common Stock used to aggregate holder disclosures.

How many institutions held HAE - HAEMONETICS CORP - Common Stock in Q2 2017?

190 institutional investors reported HAE - HAEMONETICS CORP - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

HAEMONETICS CORP - Common Stock (HAE)

CUSIP: 405024100

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 46,480,294
Total 13F shares: 55,471,370
Share change: +809,395
Total reported value: $2,190,580,845
Price per share: $39.49
Number of holders: 190
Value change: +$31,076,045
Number of buys: 119
Number of sells: 68

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 405024100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HAE - HAEMONETICS CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	14%	6,289,728	$255,175,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	10%	4,694,325	$190,449,000	—	31 Mar 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	9%	4,192,350	$170,084,000	—	31 Mar 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	7.5%	3,470,891	$140,814,000	—	31 Mar 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	5.5%	2,549,828	$103,446,000	—	31 Mar 2017	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	5.2%	2,394,135	$97,130,000	—	31 Mar 2017	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	4.8%	2,209,450	$89,637,000	—	31 Mar 2017	13F
Neuberger Berman Group LLC	13F	Company	4.3%	2,008,284	$81,476,000	—	31 Mar 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.7%	1,699,353	$68,943,000	—	31 Mar 2017	13F
HealthCor Management, L.P.	13F	Company	3.4%	1,600,000	$64,912,000	—	31 Mar 2017	13F
Black Creek Investment Management Inc.	13F	Company	3%	1,396,483	$56,655,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	2.7%	1,268,107	$51,449,000	—	31 Mar 2017	13F
Van Berkom & Associates Inc.	13F	Company	2.5%	1,142,601	$46,355,000	—	31 Mar 2017	13F
FRANKLIN RESOURCES INC	13F	Company	2.2%	1,000,000	$40,570,000	—	31 Mar 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	1.8%	850,479	$34,504,000	—	31 Mar 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.8%	818,600	$33,211,000	—	31 Mar 2017	13F
HERMES INVESTMENT MANAGEMENT LTD	13F	Company	1.7%	768,733	$31,187,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	1.6%	756,590	$30,697,000	—	31 Mar 2017	13F
ROYAL BANK OF CANADA	13F	Company	1.5%	695,465	$28,216,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	1.4%	633,069	$25,683,000	—	31 Mar 2017	13F
MACQUARIE GROUP LTD	13F	Company	1.3%	609,428	$24,724,000	—	31 Mar 2017	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	1.3%	586,290	$23,786,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.2%	580,610	$23,555,000	—	31 Mar 2017	13F
ANCHOR CAPITAL ADVISORS LLC	13F	Company	1.2%	546,965	$22,190,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1.2%	544,003	$22,071,000	—	31 Mar 2017	13F
AMERICAN CAPITAL MANAGEMENT INC	13F	Company	1.1%	533,796	$21,656,000	—	31 Mar 2017	13F
NORGES BANK	13F	Company	1.1%	510,245	$20,701,000	—	31 Mar 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.1%	509,990	$20,690,000	—	31 Mar 2017	13F
RUTABAGA CAPITAL MANAGEMENT LLC/MA	13F	Company	1.1%	493,419	$20,018,000	—	31 Mar 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	1%	475,566	$19,292,000	—	31 Mar 2017	13F
Polar Capital LLP	13F	Company	1%	474,024	$19,231,000	—	31 Mar 2017	13F
Nitorum Capital, L.P.	13F	Company	0.97%	450,484	$18,276,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.96%	446,049	$18,096,000	—	31 Mar 2017	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.87%	405,578	$16,455,000	—	31 Mar 2017	13F
Boston Trust Walden Corp	13F	Company	0.84%	388,618	$15,766,000	—	31 Mar 2017	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.78%	360,856	$14,640,000	—	31 Mar 2017	13F
SENTINEL ASSET MANAGEMENT, INC.	13F	Company	0.75%	347,131	$14,083,000	—	31 Mar 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.66%	305,099	$12,378,000	—	31 Mar 2017	13F
HEARTLAND ADVISORS INC	13F	Company	0.53%	247,674	$10,048,000	—	31 Mar 2017	13F
Fisher Asset Management, LLC	13F	Company	0.52%	241,967	$9,817,000	—	31 Mar 2017	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.51%	236,170	$9,581,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.45%	208,457	$8,457,000	—	31 Mar 2017	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.4%	185,049	$7,508,000	—	31 Mar 2017	13F
Invesco Ltd.	13F	Company	0.35%	163,379	$6,628,000	—	31 Mar 2017	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.35%	160,360	$6,506,000	—	31 Mar 2017	13F
AHL Partners LLP	13F	Company	0.31%	145,318	$5,895,000	—	31 Mar 2017	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.3%	138,672	$5,626,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.3%	138,397	$5,615,000	—	31 Mar 2017	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.28%	129,724	$5,262,000	—	31 Mar 2017	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.25%	117,978	$4,786,000	—	31 Mar 2017	13F

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2017

As of 30 Jun 2017, HAEMONETICS CORP - Common Stock (HAE) was held by 190 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,471,370 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, WELLS FARGO & COMPANY/MN, FULLER & THALER ASSET MANAGEMENT, INC., VICTORY CAPITAL MANAGEMENT INC, Neuberger Berman Group LLC, HealthCor Management, L.P., and DIMENSIONAL FUND ADVISORS LP. This page lists 190 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

176

Q2 2017 holders

190

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.